These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32239932)

  • 21. Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis.
    Pochetti G; Mitro N; Lavecchia A; Gilardi F; Besker N; Scotti E; Aschi M; Re N; Fracchiolla G; Laghezza A; Tortorella P; Montanari R; Novellino E; Mazza F; Crestani M; Loiodice F
    J Med Chem; 2010 Jun; 53(11):4354-66. PubMed ID: 20462215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPARγ S273 Phosphorylation Modifies the Dynamics of Coregulator Proteins Recruitment.
    Dias MMG; Batista FAH; Tittanegro TH; de Oliveira AG; Le Maire A; Torres FR; Filho HVR; Silveira LR; Figueira ACM
    Front Endocrinol (Lausanne); 2020; 11():561256. PubMed ID: 33329381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands.
    Mottin M; Souza PC; Ricci CG; Skaf MS
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism.
    Zheng J; Corzo C; Chang MR; Shang J; Lam VQ; Brust R; Blayo AL; Bruning JB; Kamenecka TM; Kojetin DJ; Griffin PR
    Structure; 2018 Nov; 26(11):1431-1439.e6. PubMed ID: 30146169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient expression, purification and characterisation of human full-length PPARγ2 in HEK293 cells.
    Liu J; Ormö M; Nyström AC; Claesson J; Giordanetto F
    Protein Expr Purif; 2013 Jun; 89(2):189-95. PubMed ID: 23562662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells.
    Ceni E; Crabb DW; Foschi M; Mello T; Tarocchi M; Patussi V; Moraldi L; Moretti R; Milani S; Surrenti C; Galli A
    Gastroenterology; 2006 Oct; 131(4):1235-52. PubMed ID: 17030193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design.
    Montanari R; Saccoccia F; Scotti E; Crestani M; Godio C; Gilardi F; Loiodice F; Fracchiolla G; Laghezza A; Tortorella P; Lavecchia A; Novellino E; Mazza F; Aschi M; Pochetti G
    J Med Chem; 2008 Dec; 51(24):7768-76. PubMed ID: 19053776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.
    Shang J; Brust R; Mosure SA; Bass J; Munoz-Tello P; Lin H; Hughes TS; Tang M; Ge Q; Kamenekca TM; Kojetin DJ
    Elife; 2018 Dec; 7():. PubMed ID: 30575522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis.
    Xu P; Hong F; Wang J; Wang J; Zhao X; Wang S; Xue T; Xu J; Zheng X; Zhai Y
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2690-2701. PubMed ID: 28736228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs.
    Lee MA; Tan L; Yang H; Im YG; Im YJ
    Sci Rep; 2017 Dec; 7(1):16837. PubMed ID: 29203903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Modeling Approach to Study the PPARγ-Ligand Interactions.
    Al Sharif M; Tsakovska I; Alov P; Vitcheva V; Diukendjieva A; Pajeva I
    Methods Mol Biol; 2019; 1966():261-289. PubMed ID: 31041755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands.
    Pochetti G; Godio C; Mitro N; Caruso D; Galmozzi A; Scurati S; Loiodice F; Fracchiolla G; Tortorella P; Laghezza A; Lavecchia A; Novellino E; Mazza F; Crestani M
    J Biol Chem; 2007 Jun; 282(23):17314-24. PubMed ID: 17403688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of dual ligands targeting angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ by core hopping of telmisartan.
    Zhang J; Liu X; Wang SQ; Liu GY; Xu WR; Cheng XC; Wang RL
    J Biomol Struct Dyn; 2017 Sep; 35(12):2665-2680. PubMed ID: 27602589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis and in Combo Antidiabetic Bioevaluation of Multitarget Phenylpropanoic Acids.
    Colín-Lozano B; Estrada-Soto S; Chávez-Silva F; Gutiérrez-Hernández A; Cerón-Romero L; Giacoman-Martínez A; Almanza-Pérez JC; Hernández-Núñez E; Wang Z; Xie X; Cappiello M; Balestri F; Mura U; Navarrete-Vazquez G
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29415496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of Nelumbinis folium targeting PPARγ for weight management: A molecular docking and molecular dynamics simulations study.
    Wong AR; Yang AWH; Gill H; Lenon GB; Hung A
    Comput Biol Med; 2023 Nov; 166():107495. PubMed ID: 37742414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
    Chan LS; Wells RA
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
    Muralikumar S; Vetrivel U; Narayanasamy A; N Das U
    Lipids Health Dis; 2017 Jan; 16(1):17. PubMed ID: 28109294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins.
    Álvarez-Almazán S; Bello M; Tamay-Cach F; Martínez-Archundia M; Alemán-González-Duhart D; Correa-Basurto J; Mendieta-Wejebe JE
    Biochem Pharmacol; 2017 Oct; 142():168-193. PubMed ID: 28716729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
    Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
    Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
    Shiraki T; Kodama TS; Jingami H; Kamiya N
    Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.